A Volpi

Summary

Affiliation: University of Rome Tor Vergata
Country: Italy

Publications

  1. ncbi Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system
    Antonio Volpi
    Department of Public Health, University of Rome, Rome, Italy
    Herpes 11:120A-127A. 2004
  2. ncbi Severe complications of herpes zoster
    Antonio Volpi
    Department of Public Health, University of Rome Tor Vergata, Rome, Italy
    Herpes 14:35-9. 2007
  3. ncbi Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study
    Leonardo Emberti Gialloreti
    Dipartimento di Sanita Pubblica, Universita di Roma Tor Vergata, Via Montpellier 1, 00133 Roma, Italy
    BMC Infect Dis 10:230. 2010
  4. ncbi Clinical and psychosocial correlates of acute pain in herpes zoster
    Antonio Volpi
    Department of Public Health, University of Rome Tor Vergata, Italy
    J Clin Virol 38:275-9. 2007
  5. ncbi Current management of herpes zoster: the European view
    Antonio Volpi
    Department of Public Health, University of Rome, Rome, Italy
    Am J Clin Dermatol 6:317-25. 2005
  6. ncbi Clinical and psychosocial correlates of post-herpetic neuralgia
    A Volpi
    Department of Public Health, University of Rome Tor Vergata, Rome, Italy
    J Med Virol 80:1646-52. 2008
  7. ncbi No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia
    A Gatti
    Department of Surgery, University of Rome Tor Vergata, Rome, Italy
    J Med Virol 82:1007-11. 2010
  8. ncbi Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells
    Patrizia Vernole
    Department of Public Health and Cellular Biology, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
    Mutat Res 664:39-47. 2009
  9. ncbi Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy
    Leonardo Emberti Gialloreti
    Department of Public Health, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
    Herpes 12:33-7. 2005
  10. ncbi Antiviral treatment of varicella in pediatric practice in the Latium region of Italy: results of an observational study
    Antonio Volpi
    Department of Public Health, University of Rome Tor Vergata, Rome, Italy
    Pediatr Infect Dis J 21:739-43. 2002

Collaborators

Detail Information

Publications25

  1. ncbi Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system
    Antonio Volpi
    Department of Public Health, University of Rome, Rome, Italy
    Herpes 11:120A-127A. 2004
    ..CNS complications of HHV-8 infection are rare, but the virus has been associated with AIDS-dementia complex, amyotrophic lateral sclerosis (ALS) and primary CNS lymphoma; however these links remain to be proven...
  2. ncbi Severe complications of herpes zoster
    Antonio Volpi
    Department of Public Health, University of Rome Tor Vergata, Rome, Italy
    Herpes 14:35-9. 2007
    ..Herpetic facial palsies may respond to combination therapy with an antiviral plus steroid, but further research is needed to determine the benefit of such treatments...
  3. ncbi Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study
    Leonardo Emberti Gialloreti
    Dipartimento di Sanita Pubblica, Universita di Roma Tor Vergata, Via Montpellier 1, 00133 Roma, Italy
    BMC Infect Dis 10:230. 2010
    ..It focused primarily on immunocompetent patients aged > or = 50 years who would be eligible for preventive vaccination...
  4. ncbi Clinical and psychosocial correlates of acute pain in herpes zoster
    Antonio Volpi
    Department of Public Health, University of Rome Tor Vergata, Italy
    J Clin Virol 38:275-9. 2007
    ..Acute and persistent pain are the most significant clinical manifestations of herpes zoster (HZ), but the characteristics of acute pain in HZ patients have been inadequately investigated...
  5. ncbi Current management of herpes zoster: the European view
    Antonio Volpi
    Department of Public Health, University of Rome, Rome, Italy
    Am J Clin Dermatol 6:317-25. 2005
    ..More needs to be done to educate the general public and increase awareness among primary healthcare providers of the benefits of timely and appropriate pharmacological therapy in patients with herpes zoster...
  6. ncbi Clinical and psychosocial correlates of post-herpetic neuralgia
    A Volpi
    Department of Public Health, University of Rome Tor Vergata, Rome, Italy
    J Med Virol 80:1646-52. 2008
    ..The results of this study may help physicians to identify patients with a higher risk of developing post-herpetic neuralgia and undertaking preventative strategies...
  7. ncbi No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia
    A Gatti
    Department of Surgery, University of Rome Tor Vergata, Rome, Italy
    J Med Virol 82:1007-11. 2010
    ..03 (CI 95%: 0.81-1.31)]. Further and larger prospective cohort studies are needed to ascertain whether a family history of herpes zoster is really an independent predictor of zoster in different geographical settings...
  8. ncbi Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells
    Patrizia Vernole
    Department of Public Health and Cellular Biology, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
    Mutat Res 664:39-47. 2009
    ..In MMR-deficient cells, BVDU attenuates the repair of BLM-induced DSBs and this is likely to occur via inhibition of HR...
  9. ncbi Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy
    Leonardo Emberti Gialloreti
    Department of Public Health, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
    Herpes 12:33-7. 2005
    ..The interaction between varicella and herpes zoster must also be taken into account when considering vaccination strategies, as zoster vaccination strategies may have an impact on varicella coverage...
  10. ncbi Antiviral treatment of varicella in pediatric practice in the Latium region of Italy: results of an observational study
    Antonio Volpi
    Department of Public Health, University of Rome Tor Vergata, Rome, Italy
    Pediatr Infect Dis J 21:739-43. 2002
    ..This study was designed to describe chickenpox in children and its reported management by pediatricians working for the National Health Service in the Latium region of Italy...
  11. ncbi Effect of extremely low frequency electromagnetic fields (ELF-EMF) on Kaposi's sarcoma-associated herpes virus in BCBL-1 cells
    Francesca Pica
    Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Rome, Italy
    Bioelectromagnetics 27:226-32. 2006
    ..1A/B (P < .01), but not with percentage of gp K8.1A/B-positive cells or of cells containing virions. Viral progeny produced under ELF-EMF exposure consisted mainly of defective viral particles...
  12. ncbi Cidofovir on HHV-8 in BCBL-1 cells
    Francesca Pica
    Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Rome, Italy
    Antivir Ther 9:823-5. 2004
  13. ncbi Prognostic factors of long-term CD4+count-guided interruption of antiretroviral treatment
    L Sarmati
    Clinic of Infectious Diseases, Tor Vergata University, Rome, Italy
    J Med Virol 81:481-7. 2009
    ..041 and P = 0.012, respectively). A score based on CD4+ cell counts at nadir, at baseline, at week 2 of treatment interruption, and on baseline HIV-DNA values can identify patients with a prolonged period free safely of treatment...
  14. ncbi Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells
    F Pica
    Departments of Experimental Medicine and Biochemical Sciences, Public Health and Cell Biology, and Neuroscience, University of Rome, Tor Vergata, Rome, Italy
    Blood 95:2905-12. 2000
    ..These data indicate that NGF is essential for both cell survival and virus maturation in HHV-8-infected cell lines. (Blood. 2000;95:2905-2912)..
  15. ncbi Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
    C Sarrecchia
    Department of Public Health, University of Rome Tor Vergata, Rome, Italy
    Infection 39:367-70. 2011
    ....
  16. ncbi Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon
    A Volpi
    Department of Public Health, University Tor Vergata, Rome, Italy
    J Med Virol 74:467-72. 2004
    ..019) and latent (P = 0.021) HHV-8 antigens. These results suggest that HSV-2 infection can contribute to sexual transmission of HHV-8 infection...
  17. ncbi Transmission of human herpesvirus 8: an update
    Francesca Pica
    Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
    Curr Opin Infect Dis 20:152-6. 2007
    ..Acquisition and control of human herpesvirus 8 infection have not yet been fully elucidated. This review focuses on the most recent findings on human herpesvirus 8 transmission...
  18. ncbi No protective effect of acyclovir on HIV disease progression in a cohort of HSV-2-HIV-infected individuals
    Barbara Suligoi
    Reparto AIDS e MST, Istituto Superiore di Sanita, Rome, Italy
    Antivir Ther 7:289-91. 2002
    ..In conclusion, treatment with acyclovir does not seem to prolong significantly survival to AIDS among HIV-positive individuals who are HSV-2-infected...
  19. ncbi Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis
    Francesca Pica
    Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Italy
    Antivir Ther 15:737-43. 2010
    ..Interferon (IFN)-alpha and IFN-lambda are essential for antiviral immunity, but the precise role of IFN-lambda in vivo is not yet well understood...
  20. ncbi Prevalence and determinants of herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy
    Barbara Suligoi
    Reparto AIDS e MST, Istituto Superiore di Sanita, Rome, Italy
    Sex Transm Dis 29:665-7. 2002
    ..Herpes simplex virus type 2 (HSV-2) infections may be a risk factor for the transmission of HIV. Data on the prevalence of HSV-2 infection among HIV-positive individuals are scarce...
  21. ncbi A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation
    Giuseppe Gentile
    Department of Cellular Biotechnology and Hematology, Univ, La Sapienza, Rome, Italy
    BMC Infect Dis 6:167. 2006
    ..Quantitative CMV-DNA PCR assay in plasma has been proposed to monitor CMV infection in SCT patients. We evaluated the clinical utility of pp65Ag and PCR assay in plasma of SCT recipients...
  22. ncbi Varicella immunization and herpes zoster
    Antonio Volpi
    Herpes 12:59. 2005
  23. ncbi Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients
    Giuseppe Gentile
    Department of Cellular Biotechnology and Hematology, University La Sapienza, Via Benevento 6, 00161 Rome, Italy
    J Natl Cancer Inst 97:1008-11. 2005
    ..BMT-associated HHV-8 seroconversion is relatively common in seronegative recipients from seropositive donor, but factors other than BMT may also contribute to seroconversion...
  24. ncbi Tailoring herpes labialis treatments
    Antonio Volpi
    Herpes 14:55. 2007
  25. ncbi Herpes zoster in immunocompromised patients
    Antonio Volpi
    Herpes 14:31. 2007